Variable | HR (95% CI) | P value |
---|---|---|
Sex (male vs. female) | 0.72 (0.38–1.38) | 0.325 |
Age (≤ 65 vs. > 65) | 1.07 (0.63–1.81) | 0.817 |
Diversion type (conduit vs. cutaneous ureterostomy) | 1.31 (0.80–2.16) | 0.289 |
Diversion type (neobladder vs. cutaneous ureterostomy) | 0.79 (0.36–1.84) | 0.476 |
Pathological T-stage (MIBC vs. NMIBC) | 4.96 (2.61–9.40) | < 0.001 |
Pathological N-stage (N + vs. N−) | 2.86 (1.31–6.22) | 0.008 |
Smoking history (yes vs. no) | 0.92 (0.55–1.55) | 0.756 |
Neoadjuvant chemotherapy (yes vs. no) | 0.92 (0.32–2.61) | 0.870 |
Pentafecta (10 LNs) (yes vs. no) | 0.31 (0.11–0.89) | 0.029 |